The agency said the naloxone nasal spray does not need assembly and can be used by anyone, regardless of medical training.
The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.
MILWAUKEE – The two aims of research under the initiative are to improve treatments for misuse and addiction, and to enhance pain management.
“Methadone, buprenorphine, and extended-release naltrexone ... save lives” but most people with OUD get no treatment, new report says.
Despite FDA efforts under Commissioner Scott Gottlieb to raise awareness of teen vaping, only 21% of those surveyed correctly responded that e-...
What Your Patients are Hearing
A major milestone for those seeking recovery is reaching the 3- to 5-year mark.
In this Career Choices, Dr. Ahmed talked with Dr. Stanciu, an addiction psychiatrist who provides support to clinicians managing patients with...
Substance use disorders in these patients go largely underdiagnosed and undertreated. Follow these steps to help assess and treat these often-...
From the Journals
Interventions that target parental use and emphasize positive parenting may lower adolescent opioid use.
BONITA SPRINGS, FLA. – Data suggest that patients often achieve significant improvements by reducing alcohol intake short of abstinence.